SCHEMBL13435223

SCHEMBL13435223

Cc1c(O)c2cc(C(C)C)cnc2n(OCc2ccccc2)c1=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 1/20 0.41
ALDH1A1 P00352 6/20 0.40
TSHR P16473 5/20 0.40
KDM4E B2RXH2 1/20 0.38
HBB P68871 1/20 0.38
CYP1A2 P05177 4/20 0.36
ALOX15 P16050 1/20 0.36
CYP3A4 P08684 3/20 0.35
CYP2C9 P11712 3/20 0.35
CYP2C19 P33261 3/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
IDH1 O75874 1/20 0.35
BCL2 P10415 1/20 0.35
MCL1 Q07820 1/20 0.35
MAOB P27338 2/20 0.34
CYP2D6 P10635 1/20 0.34
LMNA P02545 3/20 0.34
HIF1A Q16665 1/20 0.34
TP53 P04637 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13435221 0.85 ALDH1A1 (0.39) NPSR1ALDH1A1TSHRKDM4EHBB
SCHEMBL13435224 0.83 MAPT (0.40) NPSR1ALDH1A1TSHRKDM4EHBB
SCHEMBL16274809 0.80 CYP1A2 (0.42) ALDH1A1TSHRKDM4EHBBCYP1A2
SCHEMBL3544652 0.72 KDM4E (0.42) ALDH1A1TSHRKDM4EBCL2MCL1
SCHEMBL3514790 0.72 CASR (0.36) L3MBTL1TP53
SCHEMBL3516982 0.72 KDM4E (0.47) ALDH1A1TSHRKDM4EL3MBTL1MAOB
SCHEMBL16274825 0.72 ALDH1A1 (0.41) ALDH1A1TSHRKDM4EHBBCYP1A2
SCHEMBL3514749 0.71 KDM4E (0.47) ALDH1A1TSHRKDM4EL3MBTL1LMNA
SCHEMBL3517692 0.71 KDM4E (0.47) ALDH1A1TSHRKDM4ELMNASMN1; SMN2
SCHEMBL3514250 0.71 ALDH1A1 (0.47) ALDH1A1TSHRKDM4EL3MBTL1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100056516-A1 1-HYDROXY NAPHTHYRIDINE COMPOUNDS AS ANTI-HIV AGENTS MERCK SHARP & DOHME CORP. 2010-03-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100056516-A1 1-HYDROXY NAPHTHYRIDINE COMPOUNDS AS ANTI-HIV AGENTS RNASEH1, RNASE1, RNASEL NPSR1 2225/4885ALDH1A1 1486/4885TSHR 3624/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.